Search images on Google Product Monograph
Active Ingredients:
- brinzolamide, 1 %/W/V
- brimonidine tartrate, 0.2 %/W/V
DIN: 02435411
Dosage Form(s): SUSPENSION
Route(s) of Administration: OPHTHALMIC
Schedule: Prescription
Company: NOVARTIS PHARMACEUTICALS CANADA INC – official site
ATC:
- S01 - OPHTHALMOLOGICALS (ATC, WHO, Wiki)
- S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS (ATC, WHO)
- S01EC - Carbonic anhydrase inhibitors (ATC, WHO)
- S01EC54 - BRINZOLAMIDE, COMBINATIONS (WHO)
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 10ML
External Links for Simbrinza:
Search on Google
- Simbrinza side effects
- Simbrinza dosage
- brinzolamide side effects
- brinzolamide dosage
- brimonidine tartrate side effects
- brimonidine tartrate dosage
Novartis Pharmaceuticals Canada Inc
Go to Novartis website to see drug product details. Sometimes you can find simbrinza photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.